Envoy Medical, Inc.

Envoy Medical, Inc. (NASDAQ:COCH) is a hearing health company founded in 1995 and headquartered in White Bear Lake, Minnesota. Originally established as St. Croix Medical, Inc., the company changed its name to Envoy Medical Corporation in December 2004 before becoming Envoy Medical, Inc. The company went public in April 2021 and develops medical technologies designed to address various forms of hearing loss across the hearing loss spectrum.

Based on the available financial data, Envoy Medical appears to be in a challenging operational phase with declining revenue and increasing losses. The company's revenue dropped from $316,000 in 2023 to $225,000 in 2024, while maintaining high operating expenses typical of a medical device company engaged in research and development activities. The company's quarterly revenue has been inconsistent, ranging from $42,000 to $68,000 across recent quarters, suggesting challenges in commercializing its products or maintaining consistent sales momentum. The substantial net losses, exceeding $20 million annually, indicate the company is still in a pre-profitability stage despite being founded in 1995 and public since 2021. Without access to recent earnings call transcripts, specific strategic initiatives and product development updates are not available. However, the financial trajectory suggests the company may be facing significant operational challenges in bringing its hearing device technologies to market successfully or achieving meaningful commercial scale.